Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 66 publications
International expert consensus on gene therapy for hereditary hearing loss: based on clinical trials
International expert consensus on gene therapy for hereditary hearing loss: based on clinical trials
Journal: Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery
Published: September 07, 2026
Clinical, molecular, and immunologic determinants of survival in WHO-defined IDH-wildtype glioblastoma treated with radiotherapy: a large real-world cohort study.
Journal: Journal of neuro-oncology
Published: March 11, 2026
Feasibility and Safety of High-Dose Proton Re-Irradiation in Recurrent Pediatric Central Nervous System Tumors: A Single-Institution Retrospective Study.
Journal: Pediatric blood & cancer
Published: December 16, 2025
Outcomes after SRS and ipilimumab plus nivolumab for melanoma brain metastases following prior immune checkpoint inhibitor or targeted therapy.
Journal: The oncologist
Published: November 07, 2025
Machine learning-based prognostic subgrouping of glioblastoma: A multicenter study.
Journal: Neuro-oncology
Published: December 12, 2024
Re-Irradiation Plus Pembrolizumab: A Phase II Study for Patients with Recurrent Glioblastoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 02, 2024
A Prospective Phase I/II Clinical Trial of High-Dose Proton Therapy for Chordomas and Chondrosarcomas.
Journal: Advances in radiation oncology
Published: May 23, 2023
Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial.
Journal: Nature cancer
Published: April 29, 2023
Life-threatening altered mental status secondary to memantine in an adolescent undergoing cranial radiotherapy for medulloblastoma.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: May 24, 2022
Last Updated: 09/26/2026